Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile

Overview of attention for article published in Journal for Immunotherapy of Cancer, June 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 9 X users

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 47 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 15 publications that cite this research output.

15

The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.

Analysis of changes in plasma cytokine levels in response to interleukin 12 therapy in three clinical trials

Article in Cancer Research Communications (January 2024)

Type 1 interferon mediated signaling is indispensable for eliciting anti-tumor responses by Mycobacterium indicus pranii

Article in Frontiers in Immunology (April 2023)

FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells

Article in Nature Communications (February 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.